
Rural Health Advocates See the Looming Medicaid Cuts as Devastating
Rural People’s Voice organized a press conference last month to alert the public
Rural People’s Voice organized a press conference last month to alert the public
Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure — and without it, even it will be difficult for advanced AI solutions to succeed. The post Healthcare’s Poor Data Infrastructure Is Hindering AI Innovation in…
With HealthTap’s new direct virtual primary care program, members get ongoing access to a primary care doctor of their choosing through video visits and messaging. The post HealthTap Introduces Direct Virtual Primary Care Program appeared first on MedCity News.
Hansa Biopharma has encouraging early clinical results showing its drug imlifidase, used as a pretreatment, enabled Duchenne muscular dystrophy patients to receive the gene therapy Elevidys. Sarepta is searching for ways to mitigate excessive immune responses to Elevidys that can lead to serious and potentially fatal liver injury. The post Sarepta’s Future in Gene Therapy…
Today’s AI is not truly agentic because it’s not truly independent of you. The current crop of agents can’t set complex goals, or properly verify outputs. You have to spend a lot of effort on prompting, verifying, and system integrating. That just means the smarter you are, the smarter the AI is. It’s really amplified…
The HHS Secretary contends that federal policy financially rewarded hospitals for reporting staff vaccination rates
Premiums will rise in 2026 for most of the 22 million people who receive premium tax credits, experts say
This data note examines the role that immigrants play in the rural workforce, particularly in industries disproportionately filled by immigrants, including health care, agriculture, construction, and service.
Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…
Until a new CEO is identified, three principal executives are jointly managing CEO responsibilities at the company